{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:37:22Z","timestamp":1792895842122,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Intestinal fibrosis is a common complication in inflammatory bowel diseases with no specific therapy. Because mineralocorticoid receptor antagonism prevented inflammation and fibrosis in extra-intestinal organs, we aimed to evaluate mineralocorticoid receptor antagonism in intestinal fibrosis. Here we show that pharmacological or smooth cell specific deletion mineralocorticoid receptor antagonism prevented colon fibrosis development in male mice. In vitro, spironolactone prevented fibroblast proliferation and endothelial-to-mesenchymal transition. Neutrophil gelatinase-associated lipocalin silencing suppressed aldosterone-induced fibrosis markers and blunted colon fibrosis in mice. Chromatin immunoprecipitation showed mineralocorticoid receptor antagonist inhibits mineralocorticoid receptor binding on the neutrophil gelatinase-associated lipocalin promoter in activated smooth muscle cells. In conclusion, mineralocorticoid receptor antagonism or smooth muscle mineralocorticoid receptor deletion reduced colon fibrosis through the modulation of the neutrophil gelatinase-associated lipocalin pathway. Mineralocorticoid receptor may represent a novel therapeutic target in intestinal fibrosis and may allow the re-positioning in the field of inflammatory bowel diseases of drugs already marketed.<\/jats:p>","DOI":"10.1038\/s41467-025-61401-0","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:43:09Z","timestamp":1752136989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mineralocorticoid receptor activation contributes to intestinal fibrosis through neutrophil gelatinase-associated lipocalin in preclinical models"],"prefix":"10.1038","volume":"16","author":[{"given":"Asma","family":"Amamou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Leboutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-5210","authenticated-orcid":false,"given":"Jonathan","family":"Breton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ribet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5239-0854","authenticated-orcid":false,"given":"Pierre-Alain","family":"Thiebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"B\u00f4le-Feysot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl\u00e8ne","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanhia","family":"Aubl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Rebollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Ratel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-9580","authenticated-orcid":false,"given":"Benjamin","family":"Bonnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6605-3944","authenticated-orcid":false,"given":"Alexis","family":"Goichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louison","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moutaz","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Fermant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-1901","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Jaisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Savoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3006-5943","authenticated-orcid":false,"given":"Rachel","family":"Marion-Letellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"61401_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41575-021-00543-0","volume":"19","author":"S D\u2019Alessio","year":"2022","unstructured":"D\u2019Alessio, S. et al. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat. Rev. Gastroenterol. Hepatol. 19, 169\u2013184 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"61401_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","volume":"152","author":"F Rieder","year":"2017","unstructured":"Rieder, F., Fiocchi, C. & Rogler, G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology 152, 340\u2013350.e346 (2017).","journal-title":"Gastroenterology"},{"key":"61401_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2019.05.072","volume":"162","author":"G D\u2019Haens","year":"2022","unstructured":"D\u2019Haens, G. et al. Challenges in the pathophysiology, diagnosis, and management of intestinal fibrosis in inflammatory bowel disease. Gastroenterology 162, 26\u201331 (2022).","journal-title":"Gastroenterology"},{"key":"61401_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90660-2","volume":"11","author":"SK Vuyyuru","year":"2021","unstructured":"Vuyyuru, S. K. et al. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn\u2019s disease. Sci. Rep. 11, 11704 (2021).","journal-title":"Sci. Rep."},{"key":"61401_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cgh.2013.08.026","volume":"12","author":"GW Moran","year":"2014","unstructured":"Moran, G. W. et al. Phenotypic features of crohn\u2019s disease associated with failure of medical treatment. Clin. Gastroenterol. Hepatol. 12, 434\u2013442.e431 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"61401_CR6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1177\/2050640620947579","volume":"8","author":"I Rodr\u00edguez-Lago","year":"2020","unstructured":"Rodr\u00edguez-Lago, I. et al. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn\u2019s disease. U. Eur. Gastroenterol. J. 8, 1056\u20131066 (2020).","journal-title":"U. Eur. Gastroenterol. J."},{"key":"61401_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/pr.115.011106","volume":"68","author":"F Jaisser","year":"2016","unstructured":"Jaisser, F. & Farman, N. Emerging roles of the mineralocorticoid receptor in pathology: Toward new paradigms in clinical pharmacology. Pharm. Rev. 68, 49\u201375 (2016).","journal-title":"Pharm. Rev."},{"key":"61401_CR8","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1016\/j.crohns.2013.05.001","volume":"7","author":"C Primas","year":"2013","unstructured":"Primas, C. et al. Renal insufficiency in IBD-prevalence and possible pathogenetic aspects. J. Crohns Colitis 7, e630\u2013e634 (2013).","journal-title":"J. Crohns Colitis"},{"key":"61401_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.mce.2011.07.020","volume":"350","author":"A Odermatt","year":"2012","unstructured":"Odermatt, A. & Kratschmar, D. V. Tissue-specific modulation of mineralocorticoid receptor function by 11\u03b2-hydroxysteroid dehydrogenases: an overview. Mol. Cell Endocrinol. 350, 168\u2013186 (2012).","journal-title":"Mol. Cell Endocrinol."},{"key":"61401_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36607-6","volume":"9","author":"A Breland","year":"2019","unstructured":"Breland, A. et al. Smooth muscle transcriptome browser: offering genome-wide references and expression profiles of transcripts expressed in intestinal SMC, ICC, and PDGFR\u03b1(+) cells. Sci. Rep. 9, 387 (2019).","journal-title":"Sci. Rep."},{"key":"61401_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/gutjnl-2019-318512","volume":"69","author":"M Garg","year":"2020","unstructured":"Garg, M. et al. Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?. Gut 69, 841\u2013851 (2020).","journal-title":"Gut"},{"key":"61401_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00441-018-2860-8","volume":"374","author":"S Thorsvik","year":"2018","unstructured":"Thorsvik, S. et al. Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn\u2019s disease. Cell Tissue Res 374, 339\u2013348 (2018).","journal-title":"Cell Tissue Res"},{"key":"61401_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1177\/0192623316665927","volume":"44","author":"H Hsieh","year":"2016","unstructured":"Hsieh, H. et al. Fecal Lipocalin-2 as a sensitive and noninvasive biomarker in the tnbs crohn\u2019s inflammatory bowel disease model. Toxicol. Pathol. 44, 1084\u20131094 (2016).","journal-title":"Toxicol. Pathol."},{"key":"61401_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.115.05431","volume":"66","author":"A Tarjus","year":"2015","unstructured":"Tarjus, A. et al. Neutrophil gelatinase-associated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids. Hypertension 66, 158\u2013166 (2015).","journal-title":"Hypertension"},{"key":"61401_CR15","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1016\/j.cgh.2018.11.048","volume":"17","author":"D Bettenworth","year":"2019","unstructured":"Bettenworth, D. et al. Efficacy of endoscopic dilation of gastroduodenal crohn\u2019s disease strictures: A systematic review and meta-analysis of individual patient data. Clin. Gastroenterol. hepatology: Off. Clin. Pract. J. Am. Gastroenterological Assoc. 17, 2514\u20132522.e2518 (2019).","journal-title":"Clin. Gastroenterol. hepatology: Off. Clin. Pract. J. Am. Gastroenterological Assoc."},{"key":"61401_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jcmgh.2014.08.001","volume":"1","author":"JH Yoo","year":"2015","unstructured":"Yoo, J. H. et al. Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis. Cell Mol. Gastroenterol. Hepatol. 1, 55\u201374.e51 (2015).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"61401_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12990","volume":"92","author":"J Alfredsson","year":"2020","unstructured":"Alfredsson, J. & Wick, M. J. Mechanism of fibrosis and stricture formation in crohn\u2019s disease. Scand. J. Immunol. 92, e12990 (2020).","journal-title":"Scand. J. Immunol."},{"key":"61401_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5009\/gnl220045","volume":"17","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. Cellular and molecular mechanisms of intestinal fibrosis. Gut Liver 17, 360\u2013374 (2023).","journal-title":"Gut Liver"},{"key":"61401_CR19","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1016\/j.ajpath.2011.07.042","volume":"179","author":"F Rieder","year":"2011","unstructured":"Rieder, F. et al. Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am. J. Pathol. 179, 2660\u20132673 (2011).","journal-title":"Am. J. Pathol."},{"key":"61401_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-physiol-060821-013950","volume":"84","author":"J Barrera-Chimal","year":"2022","unstructured":"Barrera-Chimal, J., Bonnard, B. & Jaisser, F. Roles of mineralocorticoid receptors in cardiovascular and cardiorenal diseases. Annu Rev. Physiol. 84, 585\u2013610 (2022).","journal-title":"Annu Rev. Physiol."},{"key":"61401_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41581-021-00490-8","volume":"18","author":"J Barrera-Chimal","year":"2022","unstructured":"Barrera-Chimal, J., Lima-Posada, I., Bakris, G. L. & Jaisser, F. Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects. Nat. Rev. Nephrol. 18, 56\u201370 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"61401_CR22","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1038\/jid.2010.155","volume":"130","author":"TF Mitts","year":"2010","unstructured":"Mitts, T. F., Bunda, S., Wang, Y. & Hinek, A. Aldosterone and mineralocorticoid receptor antagonists modulate elastin and collagen deposition in human skin. J. Invest Dermatol 130, 2396\u20132406 (2010).","journal-title":"J. Invest Dermatol"},{"key":"61401_CR23","doi-asserted-by":"publisher","first-page":"L678","DOI":"10.1152\/ajplung.00300.2012","volume":"304","author":"IR Preston","year":"2013","unstructured":"Preston, I. R. et al. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 304, L678\u2013L688 (2013).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"61401_CR24","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.3748\/wjg.v21.i20.6180","volume":"21","author":"JA Bai","year":"2015","unstructured":"Bai, J. A. et al. SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK\/ERK\/p53 pathway in colitis. World J. Gastroenterol. 21, 6180\u20136193 (2015).","journal-title":"World J. Gastroenterol."},{"key":"61401_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.crohns.2012.04.008","volume":"7","author":"I Drygiannakis","year":"2013","unstructured":"Drygiannakis, I. et al. Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis. J. Crohns Colitis 7, 286\u2013300 (2013).","journal-title":"J. Crohns Colitis"},{"key":"61401_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.bjp.0704131","volume":"133","author":"G Miric","year":"2001","unstructured":"Miric, G. et al. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br. J. Pharm. 133, 687\u2013694 (2001).","journal-title":"Br. J. Pharm."},{"key":"61401_CR27","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s10495-006-0286-3","volume":"11","author":"SU S\u00f8nder","year":"2006","unstructured":"S\u00f8nder, S. U., Woetmann, A., Odum, N. & Bendtzen, K. Spironolactone induces apoptosis and inhibits NF-kappaB independent of the mineralocorticoid receptor. Apoptosis 11, 2159\u20132165 (2006).","journal-title":"Apoptosis"},{"key":"61401_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/08923973.2014.921690","volume":"36","author":"Y Kato","year":"2014","unstructured":"Kato, Y. et al. Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-\u03baB. Immunopharmacol. Immunotoxicol. 36, 237\u2013241 (2014).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"61401_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1053\/j.gastro.2011.07.027","volume":"141","author":"RW Stidham","year":"2011","unstructured":"Stidham, R. W. et al. Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn\u2019s disease. Gastroenterology 141, 819\u2013826.e811 (2011).","journal-title":"Gastroenterology"},{"key":"61401_CR30","doi-asserted-by":"publisher","unstructured":"Silva, I., Solas, J., Pinto, R. & Mateus, V. Chronic Experimental Model of TNBS-Induced Colitis to Study Inflammatory Bowel Disease. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms23094739 (2022).","DOI":"10.3390\/ijms23094739"},{"key":"61401_CR31","first-page":"203","volume":"66","author":"AO Sehirli","year":"2015","unstructured":"Sehirli, A. O. et al. St. John\u2019s wort may ameliorate 2,4,6-trinitrobenzenesulfonic acid colitis off rats through the induction of pregnane X receptors and\/or P-glycoproteins. J. Physiol. Pharm. 66, 203\u2013214 (2015).","journal-title":"J. Physiol. Pharm."},{"key":"61401_CR32","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ibd.21929","volume":"18","author":"LA Johnson","year":"2012","unstructured":"Johnson, L. A. et al. Spironolactone and colitis: increased mortality in rodents and in humans. Inflamm. Bowel Dis. 18, 1315\u20131324 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"61401_CR33","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/ecco-jcc\/jjab085","volume":"15","author":"KA Selin","year":"2021","unstructured":"Selin, K. A., Hedin, C. R. H. & Villablanca, E. J. Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases. J. Crohn\u2019s colitis 15, 1959\u20131973 (2021).","journal-title":"J. Crohn\u2019s colitis"},{"key":"61401_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10769-x","volume":"10","author":"P Czarnewski","year":"2019","unstructured":"Czarnewski, P. et al. Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification. Nat. Commun. 10, 2892 (2019).","journal-title":"Nat. Commun."},{"key":"61401_CR35","doi-asserted-by":"publisher","unstructured":"Suau, R. et al. Response Variability to drug testing in two models of chemically induced colitis. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24076424 (2023).","DOI":"10.3390\/ijms24076424"},{"key":"61401_CR36","doi-asserted-by":"publisher","first-page":"G220","DOI":"10.1152\/ajpgi.00077.2012","volume":"303","author":"L Rhee","year":"2012","unstructured":"Rhee, L. et al. Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G220\u2013G227 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"61401_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ibd.20753","volume":"15","author":"P Alex","year":"2009","unstructured":"Alex, P. et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 15, 341\u2013352 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"61401_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/17460441.2021.1851185","volume":"16","author":"J Bilsborough","year":"2021","unstructured":"Bilsborough, J., Fiorino, M. F. & Henkle, B. W. Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis. Expert Opin. Drug Discov. 16, 567\u2013577 (2021).","journal-title":"Expert Opin. Drug Discov."},{"key":"61401_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.002584","volume":"1","author":"RA Frieler","year":"2012","unstructured":"Frieler, R. A. et al. Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex. J. Am. Heart Assoc. 1, e002584 (2012).","journal-title":"J. Am. Heart Assoc."},{"key":"61401_CR40","doi-asserted-by":"publisher","first-page":"H989","DOI":"10.1152\/ajpheart.00073.2018","volume":"315","author":"AP Davel","year":"2018","unstructured":"Davel, A. P., Jaffe, I. Z., Tostes, R. C., Jaisser, F. & Belin de Chantem\u00e8le, E. J. New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects. Am. J. Physiol. Heart Circ. Physiol. 315, H989\u2013h999 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"61401_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1096\/fba.2019-00035","volume":"1","author":"SL Britto","year":"2019","unstructured":"Britto, S. L., Krishna, M. & Kellermayer, R. Weight loss is a sufficient and economical single outcome measure of murine dextran sulfate sodium colitis. FASEB Bioadv 1, 493\u2013497 (2019).","journal-title":"FASEB Bioadv"},{"key":"61401_CR42","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.clnu.2022.12.004","volume":"42","author":"SC Bischoff","year":"2023","unstructured":"Bischoff, S. C. et al. ESPEN guideline on Clinical Nutrition in inflammatory bowel disease. Clin. Nutr. (Edinb., Scotl.) 42, 352\u2013379 (2023).","journal-title":"Clin. Nutr. (Edinb., Scotl.)"},{"key":"61401_CR43","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1042\/CS20171592","volume":"132","author":"M Buonafine","year":"2018","unstructured":"Buonafine, M., Martinez-Martinez, E. & Jaisser, F. More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clin. Sci. (Lond.) 132, 909\u2013923 (2018).","journal-title":"Clin. Sci. (Lond.)"},{"key":"61401_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97366-5","volume":"11","author":"B Linggi","year":"2021","unstructured":"Linggi, B. et al. Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis. Sci. Rep. 11, 18243 (2021).","journal-title":"Sci. Rep."},{"key":"61401_CR45","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.117.09791","volume":"70","author":"E Mart\u00ednez-Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez-Mart\u00ednez, E. et al. Aldosterone target NGAL (neutrophil gelatinase-associated lipocalin) is involved in cardiac remodeling after myocardial infarction through NF\u03baB pathway. Hypertension 70, 1148\u20131156 (2017).","journal-title":"Hypertension"},{"key":"61401_CR46","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1161\/HYPERTENSIONAHA.111.187872","volume":"59","author":"C Latouche","year":"2012","unstructured":"Latouche, C. et al. Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system. Hypertension 59, 966\u2013972 (2012).","journal-title":"Hypertension"},{"key":"61401_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-\u03b2: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"61401_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/HYPERTENSIONAHA.122.19213","volume":"80","author":"J Ibarrola","year":"2023","unstructured":"Ibarrola, J., Lu, Q., Zennaro, M. C. & Jaffe, I. Z. Mechanism by which inflammation and oxidative stress induce mineralocorticoid receptor gene expression in aging vascular smooth muscle cells. Hypertension 80, 111\u2013124 (2023).","journal-title":"Hypertension"},{"key":"61401_CR49","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.121.17712","volume":"79","author":"B Bonnard","year":"2022","unstructured":"Bonnard, B. et al. Neutrophil gelatinase-associated lipocalin from macrophages plays a critical role in renal fibrosis via the CCL5 (Chemokine Ligand 5)-Th2 Cells-IL4 (interleukin 4) pathway. Hypertension 79, 352\u2013364 (2022).","journal-title":"Hypertension"},{"key":"61401_CR50","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jcmgh.2016.03.007","volume":"2","author":"V Singh","year":"2016","unstructured":"Singh, V. et al. Microbiota-inducible innate immune, siderophore binding protein lipocalin 2 is critical for intestinal homeostasis. Cell Mol. Gastroenterol. Hepatol. 2, 482\u2013498.e486 (2016).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"61401_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep35014","volume":"6","author":"T Toyonaga","year":"2016","unstructured":"Toyonaga, T. et al. Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages. Sci. Rep. 6, 35014 (2016).","journal-title":"Sci. Rep."},{"key":"61401_CR52","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","volume":"28","author":"AR Moschen","year":"2017","unstructured":"Moschen, A. R., Adolph, T. E., Gerner, R. R., Wieser, V. & Tilg, H. Lipocalin-2: A master mediator of intestinal and metabolic inflammation. Trends Endocrinol. Metab. 28, 388\u2013397 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"61401_CR53","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1161\/HYPERTENSIONAHA.118.11873","volume":"73","author":"C Lefranc","year":"2019","unstructured":"Lefranc, C. et al. MR (mineralocorticoid receptor) induces adipose tissue senescence and mitochondrial dysfunction leading to vascular dysfunction in obesity. Hypertension 73, 458\u2013468 (2019).","journal-title":"Hypertension"},{"key":"61401_CR54","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.117.09791","volume":"70","author":"E Martinez-Martinez","year":"2017","unstructured":"Martinez-Martinez, E. et al. Aldosterone target NGAL (neutrophil gelatinase-associated lipocalin) is involved in cardiac remodeling after myocardial infarction through NFkappaB pathway. Hypertension 70, 1148\u20131156 (2017).","journal-title":"Hypertension"},{"key":"61401_CR55","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/HYPERTENSIONAHA.113.01967","volume":"63","author":"G Galmiche","year":"2014","unstructured":"Galmiche, G. et al. Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness. Hypertension 63, 520\u2013526 (2014).","journal-title":"Hypertension"},{"key":"61401_CR56","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/nm.2891","volume":"18","author":"A McCurley","year":"2012","unstructured":"McCurley, A. et al. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat. Med 18, 1429\u20131433 (2012).","journal-title":"Nat. Med"},{"key":"61401_CR57","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.kint.2017.12.016","volume":"93","author":"J Barrera-Chimal","year":"2018","unstructured":"Barrera-Chimal, J. et al. The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling. Kidney Int 93, 1344\u20131355 (2018).","journal-title":"Kidney Int"},{"key":"61401_CR58","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/HYPERTENSIONAHA.115.06709","volume":"67","author":"A Gueret","year":"2016","unstructured":"Gueret, A. et al. Vascular smooth muscle mineralocorticoid receptor contributes to coronary and left ventricular dysfunction after myocardial infarction. Hypertension 67, 717\u2013723 (2016).","journal-title":"Hypertension"},{"key":"61401_CR59","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ki.2015.312","volume":"89","author":"CA Amador","year":"2016","unstructured":"Amador, C. A. et al. Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration. Kidney Int 89, 354\u2013362 (2016).","journal-title":"Kidney Int"},{"key":"61401_CR60","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1073\/pnas.0510847103","volume":"103","author":"T Berger","year":"2006","unstructured":"Berger, T. et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 103, 1834\u20131839 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"61401_CR61","doi-asserted-by":"publisher","unstructured":"Nakamura, T. et al. Intestinal mineralocorticoid receptor contributes to epithelial sodium channel-mediated intestinal sodium absorption and blood pressure regulation. J. Am. Heart Assoc. 7 https:\/\/doi.org\/10.1161\/jaha.117.008259 (2018).","DOI":"10.1161\/jaha.117.008259"},{"key":"61401_CR62","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz, S. et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat. Protoc. 12, 1295\u20131309 (2017).","journal-title":"Nat. Protoc."},{"key":"61401_CR63","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.clnu.2011.05.002","volume":"30","author":"A Ibrahim","year":"2011","unstructured":"Ibrahim, A. et al. Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium. Clin. Nutr. (Edinb., Scotl.) 30, 678\u2013687 (2011).","journal-title":"Clin. Nutr. (Edinb., Scotl.)"},{"key":"61401_CR64","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8430614","volume":"2018","author":"C Charpentier","year":"2018","unstructured":"Charpentier, C. et al. Dietary n-3 PUFA may attenuate experimental colitis. Mediators Inflamm. 2018, 8430614 (2018).","journal-title":"Mediators Inflamm."},{"key":"61401_CR65","doi-asserted-by":"publisher","unstructured":"Salameh, E. et al. Chronic colitis-induced visceral pain is associated with increased anxiety during quiescent phase. American journal of physiology. Gastrointestinal and liver physiology https:\/\/doi.org\/10.1152\/ajpgi.00248.2018 (2019).","DOI":"10.1152\/ajpgi.00248.2018"},{"key":"61401_CR66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","volume":"66","author":"A Marchal-Bressenot","year":"2017","unstructured":"Marchal-Bressenot, A. et al. Development and validation of the nancy histological index for UC. Gut 66, 43\u201349 (2017).","journal-title":"Gut"},{"key":"61401_CR67","unstructured":"Marion-letellier, R. https:\/\/BioRender.com\/lmfrrrn (2025)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61401-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61401-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61401-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:30:14Z","timestamp":1757219414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61401-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61401"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61401-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6318"}}